SERPINA1 and type 1 diabetes mellitus: Although several early studies on AAT indicated increased levels of this protease inhibitor in the sera of diabetic subjects [30,31,32], subsequent observations have not confirmed these findings and in fact suggest decreased serum concentrations of AAT and increased plasma serine proteinase in insulin dependent diabetes.